A bibliometric visualization of resistance to lung cancer immunotherapy: a decade of research progress (2014–2024)
This study offers a thorough overview of the most important research topics and emerging trends related to drug resistance and lung cancer immunotherapy. By integrating current knowledge, it enables researchers to swiftly identify pivotal research directions, thereby promoting in-depth development and innovation within the field and supporting the progression of clinical practice. For clinicians, this bibliometric insight provides a more scientific and precise basis for formulating treatment strategies, ultimately assisting lung cancer patients in deriving benefits from immunotherapy.
Authors
- Jianchun Wu (ORCID: https://orcid.org/0000-0002-6878-7394)
- Xiangyu Ren (ORCID: https://orcid.org/0000-0002-8207-9730)
- Yuli Wang (ORCID: https://orcid.org/0000-0001-8428-4204)
- Xiaobin Li (ORCID: https://orcid.org/0000-0002-1099-6046)
- Lanlan Yang
- Zhuo Yang (ORCID: https://orcid.org/0000-0001-5035-8156)
- Yajing Cui (ORCID: https://orcid.org/0000-0002-1468-4269)
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.3389/fonc.2025.1656967
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00